Literature DB >> 16572413

BH3-only proteins: integrated control point of apoptosis.

Tsukasa Shibue1, Tadatsugu Taniguchi.   

Abstract

Bcl-2 family proteins play central roles in the regulation of most, if not all, apoptotic pathways, and hence this family plays a critical role in oncogenesis. The Bcl-2 homology 3 (BH3)-only members of this family are "proapoptotic," promoting apoptosis by sensing cellular stresses: that is, they are activated or induced in response to stress stimuli. These BH3-only proteins then interfere with the function of "prosurvival" Bcl-2 family members, thereby promoting the progression of apoptosis. It has long been recognized that the induction and activation of each of the BH3-only proteins are subject to the type of stress stimulus. Although it was originally assumed that all the BH3-only proteins exert similar effects on the downstream apoptotic machinery, recent studies have uncovered their distinct functional properties, indicating the operation of more intricate, versatile control mechanisms of apoptosis. In this review, we will summarize recent findings on the diversity in the activation and function of BH3-only proteins. In particular, we focus on the overlapping and individual roles of 2 BH3-only proteins, Puma and Noxa, in the context of the apoptotic response induced by the tumor suppressor p53.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572413     DOI: 10.1002/ijc.21751

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.

Authors:  Lei Duan; Ricardo E Perez; Michael Hansen; Steven Gitelis; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

2.  The hepatitis C virus core protein contains a BH3 domain that regulates apoptosis through specific interaction with human Mcl-1.

Authors:  Nur Khairiah Mohd-Ismail; Lin Deng; Sunil Kumar Sukumaran; Victor C Yu; Hak Hotta; Yee-Joo Tan
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

3.  Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.

Authors:  M T de Bruijn; D A E Raats; F J H Hoogwater; W J van Houdt; K Cameron; J P Medema; I H M Borel Rinkes; O Kranenburg
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

4.  Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types.

Authors:  S R Green; A K Choudhary; I N Fleming
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

Review 5.  BH3-only proteins in apoptosis and beyond: an overview.

Authors:  E Lomonosova; G Chinnadurai
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

6.  Genes of the mitochondrial apoptotic pathway in Mytilus galloprovincialis.

Authors:  Noelia Estévez-Calvar; Alejandro Romero; Antonio Figueras; Beatriz Novoa
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

7.  Gene expression analysis of cell death induction by taurolidine in different malignant cell lines.

Authors:  Ansgar M Chromik; Stephan A Hahn; Adrien Daigeler; Annegret Flier; Daniel Bulut; Christina May; Kamran Harati; Jan Roschinsky; Dominique Sülberg; Dirk Weyhe; Ulrich Mittelkötter; Waldemar Uhl
Journal:  BMC Cancer       Date:  2010-10-30       Impact factor: 4.430

8.  Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells.

Authors:  Wensheng Liu; Wendy M Swetzig; Rajesh Medisetty; Gokul M Das
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

9.  Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry.

Authors:  Young Bong Choi; Gordon Sandford; John Nicholas
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

10.  An intermittent live cell imaging screen for siRNA enhancers and suppressors of a kinesin-5 inhibitor.

Authors:  Melody Tsui; Tiao Xie; James D Orth; Anne E Carpenter; Stewart Rudnicki; Suejong Kim; Caroline E Shamu; Timothy J Mitchison
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.